BCTX CIK: 1610820

BriaCell Therapeutics Corp.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.75
FY22:
−12.5
FY23:
−23.7
FY24:
−24.1
FY25:
−28.2
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−0.68
FY25:
−7.65
Change from FY21 to FY25
millions USD
FY21:
65.0
FY22:
−3.74
FY23:
3.95
FY24:
4.42
FY25:
45.4
millions USD
FY21:
–
FY22:
–
FY23:
−19.8
FY24:
−20.4
FY25:
9.63
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−24.6
FY25:
–

All amounts in millions USD Data source:SEC EDGAR